Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/10/24 → 31/03/27 |
Funding
- National Institute for Health Research: £630,655.90
- National Institute for Health Research: £246,667.84
- National Institute for Health Research: £197,143.63
A phase II RCT of Oral Cannabinoid versus placebo in the treatment of chemotherapy induced peripheral neuropathic pain (ACTION)
- Whalley, Heather (Principal Investigator)
- Fallon, Marie (Co-investigator)
- Hall, Peter (Co-investigator)
- Weir, Christopher (Co-investigator)